ENTITY
Shinpoong Pharmaceutical

Shinpoong Pharmaceutical (019170 KS)

77
Analysis
Health CareSouth Korea
Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.
more
08 Nov 2023 02:56

Momentum Trading Opportunities Among Top 50 Stocks in KOSPI With Highest Short Interest Ratios

We have identified 10 companies in KOSPI that have high short interest ratios, among the worst performing stocks YTD, but with strongest share...

Logo
460 Views
Share
10 Apr 2023 23:04

Shinpoong Pharmaceutical (019170 KS): Widening Operating Loss; COVID Drug Loses Steam

Shinpoong’s operating loss widened to KRW34B in 2022 from KRW14B in 2021. The company is developing oral drug for COVID. As pandemic has subsided,...

Logo
276 Views
Share
23 Dec 2022 14:05

2022 in Rear Mirror View: Top Performers From My Global Healthcare Coverage Universe

From my coverage universe, two Taiwanese stocks generated 59% and 71% returns in nearly six months. New product launch and geography expansion are...

Logo
714 Views
Share
26 Oct 2022 20:58

Shinpoong Pharmaceutical (019170 KS): Late Entry in COVID Drug Market; Legal Overhang Still Persists

Shinpoong will face competition from already established foreign and domestic oral COVID-19 drugs. Declining new cases are expected to keep the...

Logo
148 Views
Share
18 Sep 2022 01:52

A Walkthrough of Hyundai Department Store Demerger Event

This post is a detailed walkthrough of the Hyundai Department Store demerger, officially announced last Friday. It includes the demerger process...

Logo
406 Views
Share
x